Abstract
We investigated the effect of two immunosuppressant drugs, FK506 and
rapamycin, on reactive oxygen species (ROS) generation, nitric oxide (NO)
production, inducible nitric oxide synthase (iNOS) expression and nuclear
factor kappa B (NF-kB) activation in lipopolysaccharide (LPS)-activated
rat hepatocytes. Primary culture of rat hepatocytes was treated with LPS
in the presence and absence of FK506 or rapamycin. LPS increased the release
of lactate dehydrogenase (LDH) and nitrite into the culture medium. Western
blot and reverse transcription-polymerase chain reaction (RT-PCR) analyses
demonstrated increased levels of iNOS protein and mRNA. Both immunosuppressant
agents inhibited the induction of iNOS mRNA and protein stimulated by LPS.
ROS generation, assessed by flow cytometry using dichlorodihydrofluorescein
diacetate (DCFH-DA), was significantly decreased by FK506 and rapamycin.
Moreover, electrophoretic mobility shift assay (EMSA) experiments indicated
that both drugs blocked the LPS-induced activation of NF-kB. Inhibitor
kappa B (IkB) protein levels were decreased by LPS and this effect was
partly blocked by FK506 or rapamycin. In summary, both immunosuppressant
agents decreased the intracellular generation of ROS and inhibited NO production
and iNOS expression at mRNA level in association to NF-kB activation. In
addition to its capacity to reduce acute allograft rejection, this study
highlights the anti-inflammatory properties of FK506 and rapamycin.